SCID-hu mice for the study of human cancer metastasis.
Cancer metastasis involves dynamic and multistep in vivo processes. While generation of metastatic clones requires genetic alterations in cancer cells, subsequent selection of the clones is heavily influenced by interactions with the surrounding tissue microenvironment. To reproduce the complex cellular interactions that occur in human patients is, however, difficult, and has not been achieved using currently available in vitro systems or conventional animal models. The SCID-hu mouse is generated by surgical implantation of human fetal tissues into mutant mice of the severe combined immunodeficient (SCID) phenotype. The unique feature of this model is that the implanted human tissues maintain their normal architecture and function. Therefore implanted human tissues will provide relevant microenvironments for the growth and metastasis of human cancer cells. The SCID-hu mouse model, which was specifically designed for the study of human cancer biology, enables experimental investigation of cellular events involved in cancer metastasis on the basis of interactions between human cancer cells and the human tissue microenvironment. It has been demonstrated that various types of human cancer cell lines generate tumors in implanted human bone marrow and lung, organs frequently involved in metastasis in patients, upon intravenous inoculation. Tumorigenic activity in SCID-hu mice faithfully reflects the clinical features of the original cancer. Tumor formation and selection of high tumorigenic variants occur in a species-specific manner. Furthermore, it was shown that metastatic tumor formation is regulated by both cancer cells and conditions in the host organs. Conditioning of animals by either whole-body irradiation or interleukin 1alpha treatment prior to cancer cell inoculation induced metastatic tumor formation by certain small cell lung cancer (SCLC) cell lines specifically in human bone marrow. A novel gene has been identified by comparing gene expression profiles between high and low tumorigenic SCLC cells in human lung. This gene is preferentially expressed in low metastatic lines, and transfection of the gene into highly metastatic cells results in suppression of metastasis. Recent studies have shown that the gene product is involved in the apoptosis induction pathway. Collectively, our results indicate that the SCID-hu mouse will serve as a unique platform technology with which to investigate cellular events involved in human cancer metastasis, as well as to identify genes playing important roles in the growth and metastasis of human cancer, in the context of interactions between human cancer cells and human tissue environments.
Namikawa
R
R
rnamikawa@webjapan.com
Shtivelman
E
E
D000818:Animals; D019046:Bone Marrow Neoplasms / Q000473:pathology* / Q000556:secondary; D004195:Disease Models, Animal; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology* / Q000556:secondary; D051379:Mice; D016513:Mice, SCID; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D013045:Species Specificity; D014407:Tumor Cells, Cultured